Revvity, Inc. (NYSE: RVTY) Stock Competitors & Peer Comparison
See RVTY's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RVTY and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVTY | $145.18 | +12.99% | 15.6B | 26.19 | $5.35 | +0.20% |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.69% |
| TMO | $647.89 | +5.67% | 238.4B | 27.70 | $23.16 | +0.29% |
| DHR | $209.36 | +3.01% | 147.1B | 26.23 | $7.98 | +0.69% |
| NTRA | $349.44 | +2.24% | 50.2B | -265.74 | -$1.32 | N/A |
| IQV | $270.94 | +1.98% | 44.4B | 22.22 | $12.13 | N/A |
| A | $153.58 | +4.62% | 42.4B | 25.85 | $5.81 | +0.67% |
| IDXX | $519.83 | +2.02% | 40.3B | 35.92 | $14.22 | N/A |
| ILMN | $228.00 | +9.51% | 33.6B | 44.19 | $5.03 | N/A |
| WAT | $420.59 | +2.58% | 31.2B | 30.49 | $13.68 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
RVTY vs DHR-PB Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
RVTY vs TMO Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, TMO has a market cap of 238.4B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while TMO trades at $647.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas TMO's P/E ratio is 27.70. In terms of profitability, RVTY's ROE is +0.03%, compared to TMO's ROE of +0.13%. Regarding short-term risk, RVTY is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
RVTY vs DHR Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, DHR has a market cap of 147.1B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while DHR trades at $209.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas DHR's P/E ratio is 26.23. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
RVTY vs NTRA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NTRA has a market cap of 50.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NTRA trades at $349.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NTRA's P/E ratio is -265.74. In terms of profitability, RVTY's ROE is +0.03%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, RVTY is more volatile compared to NTRA. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check NTRA's competition here
IQVIA Holdings Inc. (NYSE: IQV)
RVTY vs IQV Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, IQV has a market cap of 44.4B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while IQV trades at $270.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas IQV's P/E ratio is 22.22. In terms of profitability, RVTY's ROE is +0.03%, compared to IQV's ROE of +0.22%. Regarding short-term risk, RVTY is more volatile compared to IQV. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check IQV's competition here
Agilent Technologies, Inc. (NYSE: A)
RVTY vs A Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, A has a market cap of 42.4B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while A trades at $153.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas A's P/E ratio is 25.85. In terms of profitability, RVTY's ROE is +0.03%, compared to A's ROE of +0.20%. Regarding short-term risk, RVTY is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check A's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
RVTY vs IDXX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, IDXX has a market cap of 40.3B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while IDXX trades at $519.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas IDXX's P/E ratio is 35.92. In terms of profitability, RVTY's ROE is +0.03%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, RVTY is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check IDXX's competition here
Illumina, Inc. (NASDAQ: ILMN)
RVTY vs ILMN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ILMN has a market cap of 33.6B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ILMN trades at $228.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ILMN's P/E ratio is 44.19. In terms of profitability, RVTY's ROE is +0.03%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, RVTY is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ILMN's competition here
Waters Corporation (NYSE: WAT)
RVTY vs WAT Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, WAT has a market cap of 31.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while WAT trades at $420.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas WAT's P/E ratio is 30.49. In terms of profitability, RVTY's ROE is +0.03%, compared to WAT's ROE of +0.02%. Regarding short-term risk, RVTY is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check WAT's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
RVTY vs DGX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, DGX has a market cap of 27.3B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while DGX trades at $246.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas DGX's P/E ratio is 24.39. In terms of profitability, RVTY's ROE is +0.03%, compared to DGX's ROE of +0.14%. Regarding short-term risk, RVTY is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DGX's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
RVTY vs MTD Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MTD has a market cap of 26.9B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MTD trades at $1,376.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MTD's P/E ratio is 30.58. In terms of profitability, RVTY's ROE is +0.03%, compared to MTD's ROE of -12.00%. Regarding short-term risk, RVTY is more volatile compared to MTD. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check MTD's competition here
Labcorp Holdings Inc. (NYSE: LH)
RVTY vs LH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, LH has a market cap of 25.9B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while LH trades at $324.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas LH's P/E ratio is 18.72. In terms of profitability, RVTY's ROE is +0.03%, compared to LH's ROE of +0.12%. Regarding short-term risk, RVTY is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check LH's competition here
Guardant Health, Inc. (NASDAQ: GH)
RVTY vs GH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, GH has a market cap of 23.6B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while GH trades at $176.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas GH's P/E ratio is -50.33. In terms of profitability, RVTY's ROE is +0.03%, compared to GH's ROE of +2.11%. Regarding short-term risk, RVTY is more volatile compared to GH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
RVTY vs EXAS Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas EXAS's P/E ratio is -95.37. In terms of profitability, RVTY's ROE is +0.03%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, RVTY is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
RVTY vs MEDP Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MEDP has a market cap of 17.3B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MEDP trades at $618.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MEDP's P/E ratio is 36.37. In terms of profitability, RVTY's ROE is +0.03%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, RVTY is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check MEDP's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
RVTY vs ILMNV Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ILMNV's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to ILMNV's ROE of N/A. Regarding short-term risk, RVTY is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ILMNV's competition here
PerkinElmer, Inc. (NYSE: PKI)
RVTY vs PKI Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PKI's P/E ratio is 41.45. In terms of profitability, RVTY's ROE is +0.03%, compared to PKI's ROE of +0.03%. Regarding short-term risk, RVTY is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PKI's competition here
ICON Public Limited Company (NASDAQ: ICLR)
RVTY vs ICLR Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ICLR has a market cap of 13.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ICLR trades at $174.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ICLR's P/E ratio is 14.07. In terms of profitability, RVTY's ROE is +0.03%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, RVTY is more volatile compared to ICLR. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ICLR's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
RVTY vs CRL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CRL has a market cap of 13.1B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CRL trades at $279.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CRL's P/E ratio is 27.53. In terms of profitability, RVTY's ROE is +0.03%, compared to CRL's ROE of -0.08%. Regarding short-term risk, RVTY is more volatile compared to CRL. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CRL's competition here
Qiagen N.V. (NYSE: QGEN)
RVTY vs QGEN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, QGEN has a market cap of 8.8B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while QGEN trades at $43.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas QGEN's P/E ratio is 17.55. In terms of profitability, RVTY's ROE is +0.03%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, RVTY is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check QGEN's competition here
RadNet, Inc. (NASDAQ: RDNT)
RVTY vs RDNT Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, RDNT has a market cap of 6.1B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while RDNT trades at $77.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas RDNT's P/E ratio is 167.65. In terms of profitability, RVTY's ROE is +0.03%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, RVTY is more volatile compared to RDNT. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
RVTY vs SHC Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, SHC has a market cap of 5.4B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while SHC trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas SHC's P/E ratio is 19.77. In terms of profitability, RVTY's ROE is +0.03%, compared to SHC's ROE of +0.27%. Regarding short-term risk, RVTY is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check SHC's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
RVTY vs BLLN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BLLN has a market cap of 4.8B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BLLN trades at $105.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BLLN's P/E ratio is 148.96. In terms of profitability, RVTY's ROE is +0.03%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to BLLN. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check BLLN's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
RVTY vs SYNH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas SYNH's P/E ratio is 61.40. In terms of profitability, RVTY's ROE is +0.03%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check SYNH's competition here
GRAIL Inc. (NASDAQ: GRAL)
RVTY vs GRAL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, GRAL has a market cap of 3.3B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while GRAL trades at $76.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas GRAL's P/E ratio is -7.78. In terms of profitability, RVTY's ROE is +0.03%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, RVTY is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check GRAL's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
RVTY vs OLK Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas OLK's P/E ratio is -96.59. In terms of profitability, RVTY's ROE is +0.03%, compared to OLK's ROE of -0.07%. Regarding short-term risk, RVTY is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check OLK's competition here
Veracyte, Inc. (NASDAQ: VCYT)
RVTY vs VCYT Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, VCYT has a market cap of 3.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while VCYT trades at $40.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas VCYT's P/E ratio is 20.07. In terms of profitability, RVTY's ROE is +0.03%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, RVTY is more volatile compared to VCYT. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check VCYT's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
RVTY vs WGS Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, WGS has a market cap of 2.8B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while WGS trades at $98.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas WGS's P/E ratio is 262.89. In terms of profitability, RVTY's ROE is +0.03%, compared to WGS's ROE of -0.39%. Regarding short-term risk, RVTY is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check WGS's competition here
CareDx, Inc (NASDAQ: CDNA)
RVTY vs CDNA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CDNA has a market cap of 2.7B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CDNA trades at $54.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CDNA's P/E ratio is 62.67. In terms of profitability, RVTY's ROE is +0.03%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, RVTY is more volatile compared to CDNA. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
RVTY vs PSNL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PSNL trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PSNL's P/E ratio is -14.77. In terms of profitability, RVTY's ROE is +0.03%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, RVTY is more volatile compared to PSNL. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
RVTY vs OPK Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while OPK trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas OPK's P/E ratio is -5.81. In terms of profitability, RVTY's ROE is +0.03%, compared to OPK's ROE of -0.06%. Regarding short-term risk, RVTY is more volatile compared to OPK. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
RVTY vs CSTL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CSTL has a market cap of 1.1B. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CSTL trades at $35.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CSTL's P/E ratio is -53.79. In terms of profitability, RVTY's ROE is +0.03%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, RVTY is more volatile compared to CSTL. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
RVTY vs FLGT Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, FLGT has a market cap of 604.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while FLGT trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas FLGT's P/E ratio is 2128.00. In terms of profitability, RVTY's ROE is +0.03%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, RVTY is more volatile compared to FLGT. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
RVTY vs GRALV Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas GRALV's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to GRALV's ROE of N/A. Regarding short-term risk, RVTY is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check GRALV's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
RVTY vs NEO Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NEO has a market cap of 485.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NEO trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NEO's P/E ratio is 145.31. In terms of profitability, RVTY's ROE is +0.03%, compared to NEO's ROE of -0.06%. Regarding short-term risk, RVTY is more volatile compared to NEO. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check NEO's competition here
Global Cord Blood Corporation (NYSE: CO)
RVTY vs CO Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CO's P/E ratio is 5.06. In terms of profitability, RVTY's ROE is +0.03%, compared to CO's ROE of +0.11%. Regarding short-term risk, RVTY is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CO's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
RVTY vs MYGN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MYGN has a market cap of 366.5M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MYGN trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MYGN's P/E ratio is -29.85. In terms of profitability, RVTY's ROE is +0.03%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, RVTY is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MYGN's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
RVTY vs FLDM Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas FLDM's P/E ratio is -4.74. In terms of profitability, RVTY's ROE is +0.03%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, RVTY is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check FLDM's competition here
Prenetics Global Limited (NASDAQ: PRENW)
RVTY vs PRENW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PRENW has a market cap of 277.8M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PRENW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to PRENW's ROE of -0.49%. Regarding short-term risk, RVTY is less volatile compared to PRENW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check PRENW's competition here
Biodesix, Inc. (NASDAQ: BDSX)
RVTY vs BDSX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BDSX has a market cap of 225.5M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BDSX trades at $28.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BDSX's P/E ratio is -8.74. In terms of profitability, RVTY's ROE is +0.03%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, RVTY is more volatile compared to BDSX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
RVTY vs XGN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, XGN has a market cap of 181M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while XGN trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas XGN's P/E ratio is -9.25. In terms of profitability, RVTY's ROE is +0.03%, compared to XGN's ROE of -1.22%. Regarding short-term risk, RVTY is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check XGN's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
RVTY vs IMDX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, IMDX has a market cap of 129.8M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while IMDX trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas IMDX's P/E ratio is -2.70. In terms of profitability, RVTY's ROE is +0.03%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, RVTY is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
RVTY vs GTH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas GTH's P/E ratio is -1.11. In terms of profitability, RVTY's ROE is +0.03%, compared to GTH's ROE of -1.01%. Regarding short-term risk, RVTY is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
RVTY vs GENE Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas GENE's P/E ratio is -38.25. In terms of profitability, RVTY's ROE is +0.03%, compared to GENE's ROE of -1.85%. Regarding short-term risk, RVTY is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check GENE's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
RVTY vs SERA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, SERA has a market cap of 76M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while SERA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas SERA's P/E ratio is -3.06. In terms of profitability, RVTY's ROE is +0.03%, compared to SERA's ROE of -0.47%. Regarding short-term risk, RVTY is more volatile compared to SERA. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check SERA's competition here
Precipio, Inc. (NASDAQ: PRPO)
RVTY vs PRPO Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PRPO has a market cap of 48.6M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PRPO trades at $25.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PRPO's P/E ratio is -104.77. In terms of profitability, RVTY's ROE is +0.03%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, RVTY is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check PRPO's competition here
MDxHealth S.A. (NASDAQ: MDXH)
RVTY vs MDXH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MDXH has a market cap of 34.6M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MDXH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MDXH's P/E ratio is -1.77. In terms of profitability, RVTY's ROE is +0.03%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, RVTY is more volatile compared to MDXH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check MDXH's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
RVTY vs QUCY Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, QUCY has a market cap of 30.5M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while QUCY trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas QUCY's P/E ratio is -0.06. In terms of profitability, RVTY's ROE is +0.03%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, RVTY is more volatile compared to QUCY. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check QUCY's competition here
Akumin Inc. (NASDAQ: AKU)
RVTY vs AKU Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas AKU's P/E ratio is -0.13. In terms of profitability, RVTY's ROE is +0.03%, compared to AKU's ROE of -5.32%. Regarding short-term risk, RVTY is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check AKU's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
RVTY vs CEMI Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CEMI's P/E ratio is -0.63. In terms of profitability, RVTY's ROE is +0.03%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, RVTY is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
RVTY vs ENZ Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ENZ's P/E ratio is -2.24. In terms of profitability, RVTY's ROE is +0.03%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, RVTY is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
RVTY vs PMD Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PMD's P/E ratio is -5.24. In terms of profitability, RVTY's ROE is +0.03%, compared to PMD's ROE of -0.32%. Regarding short-term risk, RVTY is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
RVTY vs ME Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ME's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to ME's ROE of -42.03%. Regarding short-term risk, RVTY is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
RVTY vs MYNZ Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, RVTY's ROE is +0.03%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, RVTY is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MYNZ's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
RVTY vs BNR Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BNR has a market cap of 12.2M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BNR trades at $13.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BNR's P/E ratio is -13.29. In terms of profitability, RVTY's ROE is +0.03%, compared to BNR's ROE of -0.13%. Regarding short-term risk, RVTY is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BNR's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
RVTY vs ADVB Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ADVB has a market cap of 11.2M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ADVB trades at $8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ADVB's P/E ratio is -73.45. In terms of profitability, RVTY's ROE is +0.03%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, RVTY is more volatile compared to ADVB. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ADVB's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
RVTY vs CHEK Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CHEK's P/E ratio is -0.43. In terms of profitability, RVTY's ROE is +0.03%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, RVTY is more volatile compared to CHEK. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
RVTY vs CNTG Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CNTG's P/E ratio is -0.23. In terms of profitability, RVTY's ROE is +0.03%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, RVTY is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CNTG's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
RVTY vs NDRA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NDRA has a market cap of 7.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NDRA trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NDRA's P/E ratio is -0.73. In terms of profitability, RVTY's ROE is +0.03%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, RVTY is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
RVTY vs APDN Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas APDN's P/E ratio is -0.10. In terms of profitability, RVTY's ROE is +0.03%, compared to APDN's ROE of -7.23%. Regarding short-term risk, RVTY is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
RVTY vs NVTA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NVTA's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, RVTY is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
RVTY vs LMDXW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, RVTY is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
RVTY vs LMDX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas LMDX's P/E ratio is -0.01. In terms of profitability, RVTY's ROE is +0.03%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, RVTY is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check LMDX's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
RVTY vs BIAFW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BIAFW has a market cap of 4.6M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BIAFW trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BIAFW's P/E ratio is 0.49. In terms of profitability, RVTY's ROE is +0.03%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, RVTY is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BIAFW's competition here
DermTech, Inc. (NASDAQ: DMTK)
RVTY vs DMTK Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas DMTK's P/E ratio is -0.04. In terms of profitability, RVTY's ROE is +0.03%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, RVTY is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
RVTY vs NOTV Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NOTV's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, RVTY is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NOTV's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
RVTY vs BIAF Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BIAF has a market cap of 2.6M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BIAF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BIAF's P/E ratio is -0.73. In terms of profitability, RVTY's ROE is +0.03%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, RVTY is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
RVTY vs SQL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas SQL's P/E ratio is -0.40. In terms of profitability, RVTY's ROE is +0.03%, compared to SQL's ROE of -30.46%. Regarding short-term risk, RVTY is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
RVTY vs AWH Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas AWH's P/E ratio is -0.09. In terms of profitability, RVTY's ROE is +0.03%, compared to AWH's ROE of +1.62%. Regarding short-term risk, RVTY is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check AWH's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
RVTY vs HTGM Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas HTGM's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, RVTY is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
RVTY vs BIOC Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BIOC's P/E ratio is -0.01. In terms of profitability, RVTY's ROE is +0.03%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, RVTY is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
RVTY vs ISPC Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, ISPC has a market cap of 184.7K. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while ISPC trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas ISPC's P/E ratio is -0.04. In terms of profitability, RVTY's ROE is +0.03%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, RVTY is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
RVTY vs SQLLW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, RVTY is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check SQLLW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
RVTY vs WGSWW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, RVTY is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check WGSWW's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
RVTY vs MEUSW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas MEUSW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, RVTY is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MEUSW's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
RVTY vs NDRAW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas NDRAW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, RVTY is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NDRAW's competition here
Danaher Corporation (NYSE: DHR-PA)
RVTY vs DHR-PA Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DHR-PA's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
RVTY vs PRXL Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas PRXL's P/E ratio is 42.97. In terms of profitability, RVTY's ROE is +0.03%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, RVTY is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PRXL's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
RVTY vs OCDX Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas OCDX's P/E ratio is -42.28. In terms of profitability, RVTY's ROE is +0.03%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, RVTY is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check OCDX's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
RVTY vs BNGOW Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas BNGOW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, RVTY is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BNGOW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
RVTY vs CHEKZ Comparison September 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 15.6B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, RVTY is priced at $145.18 on the NYSE, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 26.19, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, RVTY is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CHEKZ's competition here